Table 3.
Response to treatment | Patients, n (%) |
---|---|
Improved activity | 15 (28) |
Moderate response | 16 (30) |
No change | 16 (30) |
Worsening activity | 7 (13) |
Note: Adalimumab was stopped in 5 patients.
Response to treatment | Patients, n (%) |
---|---|
Improved activity | 15 (28) |
Moderate response | 16 (30) |
No change | 16 (30) |
Worsening activity | 7 (13) |
Note: Adalimumab was stopped in 5 patients.